Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony A Donato

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|February 5, 2014
Direct observation of residents: a model for an assessment systemAnthony A Donato
Academic Medicine : Journal of the Association of American Medical Colleges|November 29, 2012
Radiology roundsAnthony A Donato
Annals of Internal Medicine|June 21, 2016
In patients with new suspected angina, the 7-item PISA model predicted 10-year risk for coronary mortalityAnthony A Donato
Annals of Internal Medicine|December 6, 2021
In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ supportAnthony A Donato
Annals of Internal Medicine|December 6, 2021
In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free daysAnthony A Donato
Academic Medicine : Journal of the Association of American Medical Colleges|January 29, 2009
Rationing empathyAnthony A Donato
Academic Medicine : Journal of the Association of American Medical Colleges|March 28, 2006
The overhead pageAnthony A Donato
Annals of Internal Medicine|January 24, 2017
Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV riskAnthony A Donato
Annals of Internal Medicine|October 4, 2021
In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wkAnthony A Donato, Jared Green
Annals of Internal Medicine|January 2, 2023
In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptinKrysta Brown, Anthony A Donato
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|February 5, 2014
Direct observation of residents: a model for an assessment systemAnthony A Donato
Academic Medicine : Journal of the Association of American Medical Colleges|November 29, 2012
Radiology roundsAnthony A Donato
Annals of Internal Medicine|June 21, 2016
In patients with new suspected angina, the 7-item PISA model predicted 10-year risk for coronary mortalityAnthony A Donato
Annals of Internal Medicine|December 6, 2021
In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ supportAnthony A Donato
Annals of Internal Medicine|December 6, 2021
In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free daysAnthony A Donato
Academic Medicine : Journal of the Association of American Medical Colleges|January 29, 2009
Rationing empathyAnthony A Donato
Academic Medicine : Journal of the Association of American Medical Colleges|March 28, 2006
The overhead pageAnthony A Donato
Annals of Internal Medicine|January 24, 2017
Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV riskAnthony A Donato
Annals of Internal Medicine|October 4, 2021
In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wkAnthony A Donato, Jared Green
Annals of Internal Medicine|January 2, 2023
In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptinKrysta Brown, Anthony A Donato
Pageof 7